Meyka Pro banner
Standard BioTools Inc.

Stay Updated with the Latest Standard BioTools Inc. LAB News in Real Time

Find LAB news now at Meyka AI. Stay informed with the latest Standard BioTools Inc. stocks updates, including price news, market analysis, and expert insights.

LABNASDAQ
HealthcareMedical - Equipment & Services
$0.67
$0.02(3.51%)
U.S. Market opens in 62h 16m
Block Ordered to Pay $120M CFPB Restitution for Cash App Fraud Failures
📅 in about 3 hours

Block Ordered to Pay $120M CFPB Restitution for Cash App Fraud Failures

Block must pay $45M to states and $75M-$120M to Cash App users via CFPB restitution for fraud failures, account security gaps, and inadequate customer support.

Read more 12
DeepSeek Launches V4-Flash Vision Model on API with Free Image Reuse via Files API
📅 5 hours ago

DeepSeek Launches V4-Flash Vision Model on API with Free Image Reuse via Files API

DeepSeek rolled out DeepSeek-V4-Flash-Vision-Exp on its API platform on August 21, 2026. The experimental multimodal model matches DeepSeek-V4-Flash on text tasks, including reasoning and agents. It adds vision support and a free Files API for image reuse. The launch targets developers building multimodal agent workflows at scale. What the New Vision Model Brings DeepSeek-V4-Flash-Vision-Exp accepts…

Read more 12
Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge
📅 10 hours ago

Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge

Bitcoin surged 8% to $74,982 on Friday, August 21, 2026, extending a powerful weekly rally. The cryptocurrency has now climbed nearly 20% since Monday, fueled by a surprise US Treasury policy shift. Ethereum jumped toward $2,300, gaining roughly 18% in 24 hours, while XRP surged past $1.25.  Total crypto market capitalization reached $2.56 trillion, up…

Read more 12
Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B
📅 12 hours ago

Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B

Alphabet is spending more to keep up with demand for artificial intelligence. On July 22, 2026, the Google parent raised its 2026 capital expenditure forecast to $195 billion-$205 billion, up from $180 billion-$190 billion. The increase comes as Google Cloud revenue jumped 82% to $24.8 billion in the second quarter. As AI demand drives higher…

Read more 12
Japan Ends 45-Hour Overtime Cap in September, Allowing Up to 100 Hours Monthly
📅 21 hours ago

Japan Ends 45-Hour Overtime Cap in September, Allowing Up to 100 Hours Monthly

Japan ends blanket 45-hour overtime guidance in September, allowing companies with special clauses to permit up to 100 hours monthly. Labor inspectors will focus on worker health protections instead.

Read more 12
Fauci Adviser Morens Pleads Guilty to Hiding COVID Records on August 19
📅 21 hours ago

Fauci Adviser Morens Pleads Guilty to Hiding COVID Records on August 19

Dr. David Morens, former Fauci adviser, pleads guilty to conspiracy to conceal COVID-19 research records. Faces up to 5 years in prison; sentencing set for November 12.

Read more 12
Japan’s Whistleblowers Face Retaliation: New Law Tightens Protections in December
📅 1 day ago

Japan’s Whistleblowers Face Retaliation: New Law Tightens Protections in December

Japan’s amended Whistleblower Protection Act, effective December 2026, shifts burden of proof to employers and adds criminal penalties. But gaps remain for harassment and demotion cases.

Read more 12
Bitcoin Surges 7.1% to $71,880 as Trump Pushes Crypto Clarity Act on August 20
📅 1 day ago

Bitcoin Surges 7.1% to $71,880 as Trump Pushes Crypto Clarity Act on August 20

Bitcoin jumped 7.1% to $71,880 on August 20 after Trump called for passage of the Clarity Act at a White House crypto event and the Treasury doubled bond buybacks.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
📅 1 day ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20

Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.

Read more 12

LAB News FAQ